- Home
- / MEDICA SUR
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
MEDICA SUR financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$29
2024-10-29
Market Capitalization
$2.8 B
2024-10-29
Revenue
$4.5 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| MXN | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 3.6B | 3.7B | 4.5B | 6.3B | 3.9B | 4.2B | 4.5B |
| Cost of goods sold | 2.1B | 2.3B | 2.4B | 2.1B | 2.2B | 2.5B | 2.7B |
| Gross profit | 1.6B | 1.5B | 2.1B | 4.2B | 1.7B | 1.8B | 1.8B |
| Gross profit margin, % | 45.5% | 40.0% | 46.6% | 67.2% | 44.8% | 41.8% | 39.3% |
| Operating expense total | 823.3M | 763.3M | 741.0M | 2.5B | 756.0M | 846.6M | 935.1M |
| Depreciation and amortization | 430.5M | 350.9M | 344.5M | 307.4M | 171.7M | 178.7M | 194.0M |
| EBITDA | 819.7M | 716.2M | 1.3B | 1.7B | 987.9M | 927.7M | 816.6M |
| EBITDA margin, % | 22.7% | 19.4% | 30.0% | 27.6% | 25.4% | 21.9% | 18.3% |
| EBIT | 395.0M | 363.7M | 969.9M | 1.4B | 812.7M | 852.6M | 622.6M |
| EBIT margin, % | 11.0% | 9.8% | 21.7% | 22.6% | 20.9% | 20.1% | 14.0% |
| Interest income | 12.1M | 9.0M | 13.7M | 53.8M | 181.2M | 112.1M | 90.8M |
| Interest expense | 144.6M | 173.1M | 157.3M | 78.8M | 75.9M | 75.4M | 75.6M |
| Pre tax profit | 270.6M | 197.2M | 791.3M | 1.3B | 863.5M | 856.5M | 649.9M |
| Income tax expense | 101.3M | 56.6M | 232.5M | 377.6M | 245.7M | 221.5M | 188.4M |
| Net Income | 169.4M | 140.6M | 558.9M | 888.6M | 617.8M | 635.0M | 461.5M |